Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Effects of semaglutide on patient-reported outcomes in individuals with peripheral artery disease and type 2 diabetes: Findings from the STRIDE trial

Authors :

Harald Sourij1; Andrei-Mircea Catarig2; Rajitha K3; Dainis Krievins4; Bernhard Ludvik5; Kevin Mani6; Joakim Nordanstig7; Sanjana Prabhu3; Neda Rasouli8; Subodh Verma9; Marc P Bonaca10

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Download the poster (.pdf)
Keywords
Diabetes
Congress short oral presentation
GLP-1 RA
Semaglutide
Clinical